Open original FDA record ↗Recall record
- FDA identifier
- Z-0725-2026
- Company in FDA record
- Enterix, Inc.
- FDA classification date
- Nov 28, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results.
Source facts
- Action
- Consignees were initially sent an email as notification of the recall on about 09/17/2025, which was followed by a formal recall notification letter on about 09/23/2025. Consignees were instructed to immediately examine inventory and quarantine any affected units, notify customers if affected further distributed, and for those patients that have already been tested using an InSure ONE test kit that has been identified as part of the scope of this recall be retested. Once an inventory count has been received by Enterix, they will provide RMA and courier information so the recalled product can be returned for sorting and destruction.
- Initiated
- 2025-09-17
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of California, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Washington, West Virginia and the country of Philippines.
- Recall number
- Z-0725-2026
- Recall status
- Open, Classified
- CDRH record ID
- 216613
- FDA classified
- 2025-11-28
- Recall event number
- 97802